USANA Health Sciences Inc. (USNA) was a big mover last session with its shares surging over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now down over 6% in the past one-month time frame.
This manufacturer of nutritional and personal care products has seen no estimate revision in the last 30 days while the Zacks Consensus Estimate has moved higher over the same period. This implies more solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.
USANA currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other top-ranked Medical Drug stocks worth considering include Endocyte, Inc. (ECYT), Lannett Company, Inc. (LCI) and Ariad Pharmaceuticals Inc. (ARIA). While ECYT sports a Zacks Rank #1 (Strong Buy), LCI and ARIA bear the same Zacks Rank as USANA.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment